Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2015

Nov 3, 2015

29821_dirs_2015-11-03_d34519a0-bc43-49c0-8284-4e981c82df43.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-11-01

Reporting Person: Mahoney Michael F (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-01 Common Stock M 341669.0000 $0.0000 Acquired 1596252.0000 Direct
2015-11-01 Common Stock F 160927.0000 $18.2800 Disposed 1435325.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-11-01 Deferred Stock Units $0.0000 M 341669.0000 Disposed Common Stock (341669.0000) Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: The award vests in five equal installments beginning on November 1, 2012, the first anniversary of the date of grant.